Health In Tech, Inc. (HIT)

Health In Tech Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022
Revenue	20.58	19.15	5.77
Revenue Growth (YoY)	-	231.93%	-
Cost of Revenue	-	2.3	0.33
Gross Profit	16.81	16.85	5.44
Selling, General & Admin	-	11.46	4.44
Research & Development	-	2	0.79
Operating Expenses	-	13.46	5.23
Operating Income	2.84	3.38	0.21
Interest Expense / Income	0.23	-0.04	0
Other Expense / Income	-	-1.48	0.32
Pretax Income	2.61	3.42	0.2
Income Tax	0.76	0.95	0.12
Net Income	1.84	3.96	-0.24
Net Income Common	1.84	2.48	0.08
Net Income Growth	-	3005.84%	-
Free Cash Flow	0.01	0.38	-0.44
Gross Margin	81.67%	87.97%	94.21%
Operating Margin	13.80%	17.66%	3.56%
Profit Margin	8.96%	12.93%	1.38%
Free Cash Flow Margin	0.06%	2.01%	-7.57%
Effective Tax Rate	29.27%	27.62%	60.33%
EBITDA	3.37	5.2	-0.12
EBITDA Margin	16.36%	27.17%	-2.04%
Depreciation & Amortization	0.53	0.34	-
EBIT	2.84	4.86	-0.12
EBIT Margin	13.80%	25.40%	-2.04%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).